Syntec Optics Holdings Inc (NASDAQ:OPTX) reported a new $4.6 million purchase order for manufacturing laser blood-test cartridges and optical reader subsystems that are used in clinical laboratories and hospitals around the world. The company said the announcement coincided with a 4.3% rise in its shares during premarket trading on Tuesday.
The order is for continued production of disposable point-of-care cartridges designed to measure hemoglobin, electrolytes, and metabolites in clinical settings. These devices are employed across hospital networks and trauma centers, where deployments typically include multiple units operating in parallel in areas such as Intensive Care Units, Neonatal Intensive Care Units, operating rooms, and emergency departments.
Syntec Optics highlighted the speed advantage of the blood gas analyzers that form part of the product family. The analyzers provide critical oxygen, carbon dioxide, and clotting risk measurements in approximately one minute, a marked difference from the hours-long turnaround associated with traditional central laboratories. In intensive care, arterial blood gases are typically checked two to three times per day to support management of mechanical ventilation and to monitor metabolic stability.
Company executives signaled continuity between the firm’s expanding manufacturing work in space and defense sectors and its biomedical product lines. Chief Financial Officer Dean Rudy noted that while the company is advancing production capabilities for aerospace and defense applications, the biomedical business continues to generate stable, diversified, recurring revenue from products with long life cycles.
Operationally, Syntec has already shipped roughly $500,000 in goods toward this order, according to Director of Operations Jen Gale, and the company plans to complete full delivery by the third quarter. Facilities that use these systems typically perform between 400 and 750 tests per month, with high-volume clinical units processing 15 to 40 patient samples in every 24-hour period.
The order underscores ongoing demand for rapid point-of-care testing in hospital environments, where fast turnaround on blood gas and related measurements can be critical to patient management. Syntec’s mix of recurring biomedical revenue alongside its space and defense manufacturing work was presented by management as a source of diversification for the company’s top line.
Summary
- Syntec Optics received a $4.6 million purchase order for laser blood-test cartridges and optical reader subsystems.
- Shares traded up 4.3% in premarket trading following the announcement.
- Approximately $500,000 of the order has been shipped; full delivery is targeted by the third quarter.
Details
- The cartridges test hemoglobin, electrolytes, and metabolites and are used across hospital networks and trauma centers.
- Blood gas analyzers deliver oxygen, carbon dioxide, and clotting risk data in about one minute, compared with hours for central labs.
- Typical usage ranges from 400 to 750 tests per month per hospital or department, with busy units processing 15 to 40 samples per 24 hours.